Regulation of oral immune tolerance by the microbiome in food allergy

•Food allergy (FA) is characterized by pathogenic dysbiosis.•The dysbiosis in FA disrupts oral tolerance to dietary antigens by impairing the generation of ROR-γt+ induced regulatory T cells.•Therapy with Clostridiales and Bacteroidales commensal bacteria activates a MyD88- ROR-γt axis in nascent iT...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in immunology 2019-10, Vol.60, p.141-147
Hauptverfasser: Stephen-Victor, Emmanuel, Chatila, Talal A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Food allergy (FA) is characterized by pathogenic dysbiosis.•The dysbiosis in FA disrupts oral tolerance to dietary antigens by impairing the generation of ROR-γt+ induced regulatory T cells.•Therapy with Clostridiales and Bacteroidales commensal bacteria activates a MyD88- ROR-γt axis in nascent iTreg cells to restore immune tolerance in FA. The steep rise in the incidence and prevalence of food allergy (FA) in the last few decades have focused attention of environmental mechanisms which act to promote disease, chief among which is the microbiome. Recent studies have now established the presence of pathogenic dysbiosis in FA that could be precipitated by a variety of environmental insults, including among others antibiotic usage and mode of delivery, that act to subvert the immune regulatory response that enforce tolerance to dietary antigens. A key attribute of this dysbiosis is the loss of Clostridial bacterial species that act to promote the formation of food allergen-specific nascent regulatory T cells in the gut. Significantly, different immunoprotective commensal bacteria, including members of the Clostridiales and Bacteroidales orders act to induce the transcription factor RORγt in nascent Treg cells via an upstream MyD88-dependent mechanism to promote tolerance to dietary antigens. Activation of this axis is disrupted by the dysbiosis, and can be restored by treatment with therapeutic microbiota. These findings highlight the potential for novel microbiota-based approaches to the prevention and treatment of the FA epidemic.
ISSN:0952-7915
1879-0372
1879-0372
DOI:10.1016/j.coi.2019.06.001